Shilpa Medicare Ltd

Announcement Under Regulation 30 Of The SEBI (LODR) Regulations 2015

06:57 PM, 6th Feb 2026

Shilpa announces the filing of ROTIGOTINE Transdermal System USP its First Transdermal patch ANDA to the USFDA